Proliverenol Supplementation for Non-Alcoholic Fatty Liver Disease (NAFLD)

Conditions: Non-Alcoholic Fatty Liver Disease (NAFLD) Interventions: Drug: Proliverenol; Drug: Placebo caplets of Proliverenol Sponsors: Dexa Medica Group; PT Equilab International Recruiting

https://clinicaltrials.gov/study/NCT06127225

Source: ClinicalTrials.gov - November 10, 2023 Category: Research Source Type: clinical trials